Method for quantitatively detecting levo-lansoprazole and dextro-lansoprazole in biological sample by means of ultra-high performance convergence chromatography-mass spectrometry

A technology of L-lansoprazole and D-lansoprazole, which is applied in the field of drug detection, can solve the problems of high equipment and technical requirements, narrow application range, incompatible mass spectrometry, etc., and achieve no endogenous matrix interference, sample The effect of small amount and high sensitivity

Inactive Publication Date: 2019-02-01
GUANGDONG INST OF APPLIED BIOLOGICAL RESOURCES +1
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, both GC and HPCE have the advantages of high efficiency and high sensitivity, but the scope of application is narrow
The advantage of HPLC is that it is the most widely used, does not require high temperature, and reduces isomerization, but it is usually separated in normal phase mode. The mobile phase is usually n-hexane and isopropanol or other normal phase solvents, and is not compatible with mass spectrometry.
SFC has the advantages of high separation efficiency of GC and HPCE and wide application range of HPLC, but it needs to be operated under high pressure, which requires high equipment and technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for quantitatively detecting levo-lansoprazole and dextro-lansoprazole in biological sample by means of ultra-high performance convergence chromatography-mass spectrometry
  • Method for quantitatively detecting levo-lansoprazole and dextro-lansoprazole in biological sample by means of ultra-high performance convergence chromatography-mass spectrometry
  • Method for quantitatively detecting levo-lansoprazole and dextro-lansoprazole in biological sample by means of ultra-high performance convergence chromatography-mass spectrometry

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Ultra high performance convergence chromatography (UPCC) and triple quadrupole mass spectrometry (MS / MS) are combined to detect the chiral drugs L-lansoprazole and dexlansoprazole in plasma; the detection method of the present invention is specific, Methodological verification of standard curve, lower limit of quantification (LLOQ), residue, precision and accuracy, matrix effect, extraction recovery rate, and stability of autosampler at 24h temperature.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
linear rangeaaaaaaaaaa
Login to view more

Abstract

The invention provides a method for quantitatively detecting the levo-pantoprazole and the dextro-pantoprazole in a biological sample by means of ultra-high performance convergence chromatography-massspectrometry. According to the method, after the biological sample to be detected is subjected to pretreatment, the liquid to be detected is subjected to the ultra-high performance convergence chromatography-mass spectrometry detection; according to the peak area and the standard curve of levo-lansoprazole/dextro-lansoprazole and an internal standard in a detection spectrum, the concentration ofthe levo-lansoprazole and the dextro-lansoprazole in the biological sample to be detected is calculated through an internal standard method; the invention combines the ultra-high performance convergence chromatography (UPCC) with a triple quadrupole mass spectrometry (MS/MS) for quantitative detection of chiral drugs in biological samples for the first time; and the method provided by the invention is high in sensitivity, can meet the separation of chiral drugs in biological samples with low sample volume, low content, and complex matrix, and is short in detection time and low in cost.

Description

Technical field [0001] The invention relates to the technical field of drug detection, in particular to a method for quantitatively detecting L-lansoprazole and dexlansoprazole in biological samples by ultra-efficient convergence chromatography-mass spectrometry. Background technique [0002] Chiral drugs (Stereoisomeric Drugs) refer to drugs containing chiral centers or asymmetric centers in the molecular structure, which include a single enantiomer and a mixture of two or more enantiomers. The physical and chemical properties of these enantiomers are basically similar, only the optical rotation is different. Studies have shown that about 60% of commonly used drugs have one or more chiral centers, and about 50% of the more than 2,000 commonly used drugs listed in the US Pharmacopoeia are chiral drugs. The chiral drug market is still expanding year by year, and chiral drugs have become an important direction for the research and development of new molecular entities. In the hum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/72
CPCG01N30/02G01N30/7266
Inventor 杨威林俊粒张家伟盛亚丽汪巨峰
Owner GUANGDONG INST OF APPLIED BIOLOGICAL RESOURCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products